期刊文献+

血清可溶性血管内皮生长因子受体1/胎盘生长因子比值作为预测子痫前期患病风险的价值 被引量:8

The significance of the ratio of serum soluble fms-like tyrosine kinase-1/placenta growth factor for predicting development of preeclampsia
下载PDF
导出
摘要 目的检测正常妊娠和子痫前期孕妇在中期妊娠时血清可溶性血管内皮生长因子受体1(sFlt-1)、胎盘生长因子(PLGF)水平,探讨母血sFlt-1/PLGF比值是否可作为预测孕妇发生子痫前期的标志物。方法用酶联免疫吸附试验(ELISA)检测200例正常妊娠妇女、57例子痫前期孕妇妊娠中期血清PLGF和sFlt-1水平,计算sFlt-1/PLGF比值。结果子痫前期组血清sFlt-1浓度[(1 385.0±178.8)ng/L]明显高于正常妊娠组[(1 087.3±122.7)ng/L](P<0.01),血清PLGF浓度[(501.9±86.3)ng/L]明显低于正常妊娠组[(712.7±103.6)ng/L],(P<0.01);子痫前期组sFlt-1和PLGF水平呈负相关(r=-0.629,P<0.01),正常妊娠组sFlt-1和PLGF水平呈正相关(r=0.682,P<0.01)。在妊娠中期,sFlt-1/PLGF比值>1.9时,预测子痫前期的敏感性为89.5%,特异性为97.5%。结论妊娠中期血清sFlt-1水平增高伴有PLGF水平降低与子痫前期的发病密切相关,sFlt-1/PLGF比值可以作为预测子痫前期的标志物。 Objective To detect the levels of serum soluble fms-like tyrosine kinase-1(sFlt-1) and placenta growth factor(PLGF) during the second trimester in the serum of women in normal pregnancy and women who subsequently develop preeclampsia,and investigate the role of sFlt-1/PLGF ratio as an early marker for the development of preeclampsia.Methods The serum levels of PLGF and sFlt-1 in 200 healthy pregnant women and 57 women with preeclampsia were determined by enzyme-linked immunosorbent assay(ELISA).The ratio of sFlt-1/PLGF was calculated.Results The serum sFlt-1 levels were significantly higher in the women with preeclampsia [(1 385.0±178.8)ng/L] than in healthy controls [(1 087.3±122.7)ng/L](P0.01).The PLGF levels were significantly lower in the women with preeclampsia [(501.9±86.3)ng/L] than in healthy controls [(712.7±103.6)ng/L](P0.01).In the women with preeclampsia,sFlt-1 levels were negatively correlated with PLGF(r =-0.629,P0.01),and in healthy controls,there were positively correlations between the PLGF and sFlt-1 levels(r =0.682,P0.01).In the second trimester,the ratio of sFlt-1/PLGF was 1.9,and its sensitivity and specificity were 89.5% and 97.5%.Conclusions Preeclampsia showes a strong association with increased levels of sFlt-1 and decreased levels of PLGF in the second trimester.The sFlt-1/PLGF ratio may be an early marker for the development of preeclampsia.
出处 《检验医学》 CAS 北大核心 2010年第10期784-786,共3页 Laboratory Medicine
基金 江苏省常州市科技规划项目(CS2008224)
关键词 血管内皮生长因子受体1 胎盘生长因子 子痫前期 Fms-like tyrosine kinase-1 Placenta growth factor Preeclampsia
  • 相关文献

参考文献8

  • 1Sibai B,Dekker G,Kupferminc M.Pre-eclampsia[J].Lancet,2005,365(9461):785-799.
  • 2Levine RJ,Maynard SE,Qian C,et al.Circulating angiogenic factors and the risk of preeclampsia[J].N Engl J Med,2004,350(7):672-683.
  • 3乐杰主编.妇产科学[M].第7版.北京:人民卫生出版社,2009.271-272.
  • 4Chaiworapongsa T,Romero R,Kim YM,et al.Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia[J].J Matern Fetal Neonatal Med,2005,17(1):3-18.
  • 5Romero R,Nien JK,Espinoza J,et al.A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate[J].J Matern Fetal Neonatal Med,2008,21(1):9-23.
  • 6Moore Simas TA,Crawford SL,Solitro MJ,et al.Angiogenic factors for the prediction of preeclampsia in high-risk women[J].Am J Obstet Gynecol,2007,197(3):244.e1-244.e8.
  • 7Koga K,Osuga Y,Yoshino O,et al.Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia[J].J Clin Endocrinol Metab,2003,88(5):2348-2351.
  • 8Chaiworapongsa T,Romero R,Espinoza J,et al.Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia[J].Am J Obstet Gynecol,2004,190(6):1541-1547.

共引文献45

同被引文献88

  • 1史浩,陈楠,张文,任红,徐耀文,沈平雁,王伟铭,俞海瑾,李晓,冯晓蓓.简化MDRD公式预测慢性肾病患者肾小球滤过率的应用评价及校正[J].中国实用内科杂志,2006,26(5):665-669. 被引量:88
  • 2乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:92-99.
  • 3许文荣,王建中.临床血液学与检验[M].北京:人民卫生出版社,2010:320-322.
  • 4SchiettecatteJ ,Russcher H,Anckaert E,et at. Multicenter evalua?tion of the first automated Elecsys sFlt-l and PIGF assays in normal pregnancies and preeclampsia[J]. Clin Biochem, 20 IO, 43 (9) : 768-770.
  • 5Cudmore MJ, Ramma W, Cai M, et al. Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFIt-I) from human placenta[J] . AmJ Obstet Gynecol, 2012 ,206(3) :253 ,eI0-15.
  • 6Yang F .Jin C,Jiang YJ ,et al. Potential role of soluble VEGFR-I in antiangiogenesis therapy for cancer[J]. Expert Rev Anticancer Ther,2011, 11(4) :541-549.
  • 7Nadarajah VD,Min RG,JudsonJP,et al. Maternal plasma soluble fms -like tyrosine kinase -I and placental growth factor levels as biochemical markers of gestational hypertension for Malaysian mothers[J].J Obstet Gynaecol Res ,2009,35(5) : 855-863.
  • 8Al -Ani B,Hewett PW,Cudmore MJ,et al. Activation of pro?teinaseactivated receptor 2 stimulates soluble vascular endothelial growth factor receptor I release via epidermal growth factor receptor transactivation in endothelial cells[J]. Hypertension,2010,55(3): 689-697.
  • 9Sunderji S, Gaziano E, Wothe D,et al. Automated assays for sVEGF RI and PIGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study[J]' AmJ Obstet Gynecol, 2010,202 (1) :40.el-40.e7.
  • 10Rohra DK,Zeb A, Qureishi RN ,et al. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-I and placental growth factor[J]' Nat! MedJ India,20l2, 25 (2): 68-73.

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部